347 related articles for article (PubMed ID: 15466983)
21. Correlation between the international consensus definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and patient-centered outcomes in advanced non-small cell lung cancer.
LeBlanc TW; Nipp RD; Rushing CN; Samsa GP; Locke SC; Kamal AH; Cella DF; Abernethy AP
J Pain Symptom Manage; 2015 Apr; 49(4):680-9. PubMed ID: 25461669
[TBL] [Abstract][Full Text] [Related]
22. A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement.
Rodrigo R; Korantzopoulos P; Cereceda M; Asenjo R; Zamorano J; Villalabeitia E; Baeza C; Aguayo R; Castillo R; Carrasco R; Gormaz JG
J Am Coll Cardiol; 2013 Oct; 62(16):1457-65. PubMed ID: 23916928
[TBL] [Abstract][Full Text] [Related]
23. Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters.
Mantovani G; Madeddu C; Gramignano G; Lusso MR; Mocci M; Massa E; Ferreli L; Astara G; Macciò A; Serpe R
J Exp Ther Oncol; 2003; 3(4):205-19. PubMed ID: 14567291
[TBL] [Abstract][Full Text] [Related]
24. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.
Fearon KC; Von Meyenfeldt MF; Moses AG; Van Geenen R; Roy A; Gouma DJ; Giacosa A; Van Gossum A; Bauer J; Barber MD; Aaronson NK; Voss AC; Tisdale MJ
Gut; 2003 Oct; 52(10):1479-86. PubMed ID: 12970142
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy-Related Toxicity, Nutritional Status and Quality of Life in Precachectic Oncologic Patients with, or without, High Protein Nutritional Support. A Prospective, Randomized Study.
Ziętarska M; Krawczyk-Lipiec J; Kraj L; Zaucha R; Małgorzewicz S
Nutrients; 2017 Oct; 9(10):. PubMed ID: 29019951
[TBL] [Abstract][Full Text] [Related]
26. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study.
Sánchez-Lara K; Turcott JG; Juárez E; Guevara P; Núñez-Valencia C; Oñate-Ocaña LF; Flores D; Arrieta O
Nutr Cancer; 2012; 64(4):526-34. PubMed ID: 22489794
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia.
Burns CP; Halabi S; Clamon G; Kaplan E; Hohl RJ; Atkins JN; Schwartz MA; Wagner BA; Paskett E
Cancer; 2004 Jul; 101(2):370-8. PubMed ID: 15241836
[TBL] [Abstract][Full Text] [Related]
28. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy.
Ravasco P; Monteiro-Grillo I; Marques Vidal P; Camilo ME
Head Neck; 2005 Aug; 27(8):659-68. PubMed ID: 15920748
[TBL] [Abstract][Full Text] [Related]
29. [Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome].
Inui A
Rinsho Byori; 2006 Oct; 54(10):1044-51. PubMed ID: 17133993
[TBL] [Abstract][Full Text] [Related]
30. Cytokines and cancer anorexia cachexia syndrome.
Bennani-Baiti N; Davis MP
Am J Hosp Palliat Care; 2008; 25(5):407-11. PubMed ID: 18403577
[TBL] [Abstract][Full Text] [Related]
31. [Effect of antioxidant supplementation over oxidative stress and quality of life in cervical cancer].
Fuchs-Tarlovsky V; Bejarano-Rosales M; Gutiérrez-Salmeán G; Casillas MA; López-Alvarenga JC; Ceballos-Reyes GM
Nutr Hosp; 2011; 26(4):819-26. PubMed ID: 22470030
[TBL] [Abstract][Full Text] [Related]
32. Beyond anorexia -cachexia. Nutrition and modulation of cancer patients' metabolism: supplementary, complementary or alternative anti-neoplastic therapy?
Laviano A; Seelaender M; Sanchez-Lara K; Gioulbasanis I; Molfino A; Rossi Fanelli F
Eur J Pharmacol; 2011 Sep; 668 Suppl 1():S87-90. PubMed ID: 21810420
[TBL] [Abstract][Full Text] [Related]
33. Cachexia and oxidative stress in cancer: an innovative therapeutic management.
Mantovani G; Madeddu C; Macciò A
Curr Pharm Des; 2012; 18(31):4813-8. PubMed ID: 22632861
[TBL] [Abstract][Full Text] [Related]
34. The cancer cachexia syndrome.
Puccio M; Nathanson L
Semin Oncol; 1997 Jun; 24(3):277-87. PubMed ID: 9208884
[TBL] [Abstract][Full Text] [Related]
35. Current pharmacotherapy options for cancer anorexia and cachexia.
Macciò A; Madeddu C; Mantovani G
Expert Opin Pharmacother; 2012 Dec; 13(17):2453-72. PubMed ID: 23072481
[TBL] [Abstract][Full Text] [Related]
36. Eicosapentaenoic acid in cancer improves body composition and modulates metabolism.
Pappalardo G; Almeida A; Ravasco P
Nutrition; 2015 Apr; 31(4):549-55. PubMed ID: 25770317
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms and treatment of cancer cachexia.
Argilés JM; López-Soriano FJ; Busquets S
Nutr Metab Cardiovasc Dis; 2013 Dec; 23 Suppl 1():S19-24. PubMed ID: 22749678
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy evaluation of an oral powder supplement enriched with eicosapentaenoic acid in cancer patients].
Gómez-Candela C; Villarino Sanz M; Horrisberger A; Loria Kohen V; Bermejo LM; Zamora Auñón P
Nutr Hosp; 2011; 26(6):1385-93. PubMed ID: 22411387
[TBL] [Abstract][Full Text] [Related]
39. Antimyopathic effects of carnitine and nicotine.
Laviano A; Meguid MM; Guijarro A; Muscaritoli M; Cascino A; Preziosa I; Molfino A; Rossi Fanelli F
Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):442-8. PubMed ID: 16778574
[TBL] [Abstract][Full Text] [Related]
40. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
